Bioprocessing 4.0 depends on integrated software, and MilliporeSigma just rolled out a new option.
Deal covers the production of Clevegen, a humanized anti-Clever-1 antibody.
Sponsor: Lonza REGISTER NOW Broadcast Date: June 4, 2020 Time: 8:00 am PT, 11:00 am ET, 17:00 CET In the biopharma industry, there currently is a need to increase production capacity to meet the analytical demands of process development...
Sponsored by: SartoriusSartorius has long been a leader in bioprocessing and its expertise is clearly on display in this e-book, specifically in the company’s adoption of advanced monitoring techniques in bioproduction. Here you will read about how Sartorius uses state-of-the art biosensors to carry out critical monitoring procedures during bioreactor operations.
COVID-19 has increased vaccine sector demand for contractors with next generation QC and formulation technologies.
Taking a close look at the pros and cons of an increasingly popular biomanufacturing methodology.
Industry bioprocessing needs are diversifying, and the technology acquired from Danaher is intended to close the gaps.
The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that reduce drug quality and increase production costs. Researchers have now introduced a CRISPR-Cas9 genome-editing technique that can eliminate up to 70% of the contaminating protein by mass in recombinant-protein drugs produced by CHO cells, workhorses of biotherapeutic protein production.
Please wait while you are redirected to the right page...